ES2061021T3 - Tratamiento de la dependencia de ventilador con hormona del crecimiento. - Google Patents

Tratamiento de la dependencia de ventilador con hormona del crecimiento.

Info

Publication number
ES2061021T3
ES2061021T3 ES90905100T ES90905100T ES2061021T3 ES 2061021 T3 ES2061021 T3 ES 2061021T3 ES 90905100 T ES90905100 T ES 90905100T ES 90905100 T ES90905100 T ES 90905100T ES 2061021 T3 ES2061021 T3 ES 2061021T3
Authority
ES
Spain
Prior art keywords
treatment
growth hormone
dependency
fan
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905100T
Other languages
English (en)
Inventor
Douglas W Wilmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Application granted granted Critical
Publication of ES2061021T3 publication Critical patent/ES2061021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA EL TRATAMIENTO DE DISFUNCION PULMONAR EN UN MAMIFERO, QUE INCLUYE LA ADMINISTRACION DE HORMONA DE CRECIMIENTO A DICHO MAMIFERO. EN OTRA REALIZACION EN LA QUE LA DISFUNCION PULMONAR ORIGINA LA DEPENDENCIA DE RESPIRACION ARTIFICIAL, EL USO DEL METODO DE ESTA INVENCION FAVORECE LA RETIRADA DEL SOPORTE DE RESPIRACION MECANICA.
ES90905100T 1989-02-07 1990-02-02 Tratamiento de la dependencia de ventilador con hormona del crecimiento. Expired - Lifetime ES2061021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/306,978 US5089475A (en) 1989-02-07 1989-02-07 Treatment of ventilator dependency with growth hormone

Publications (1)

Publication Number Publication Date
ES2061021T3 true ES2061021T3 (es) 1994-12-01

Family

ID=23187728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905100T Expired - Lifetime ES2061021T3 (es) 1989-02-07 1990-02-02 Tratamiento de la dependencia de ventilador con hormona del crecimiento.

Country Status (10)

Country Link
US (1) US5089475A (es)
EP (1) EP0457848B1 (es)
JP (1) JP2855169B2 (es)
AT (1) ATE110961T1 (es)
AU (1) AU634221B2 (es)
CA (1) CA2045546C (es)
DE (1) DE69012316T2 (es)
DK (1) DK0457848T3 (es)
ES (1) ES2061021T3 (es)
WO (1) WO1990009189A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101840L (sv) * 1991-06-14 1992-12-15 Kabi Pharmacia Ny medicinsk anvaendning
AU1942995A (en) * 1994-03-15 1995-10-03 K.U. Leuven Research & Development New use of growth hormone
US8043224B2 (en) * 2000-07-12 2011-10-25 Dimicine Research It, Llc Telemedicine system
WO2004019761A2 (en) * 2002-08-28 2004-03-11 The Board Of Trustees Of The University Of Illinois Methods of treating age-related defects and diseases
US7635673B2 (en) 2003-03-25 2009-12-22 The Board Of Trustees Of The University Of Illinois Methods of inhibiting tumor cell proliferation
ATE501252T1 (de) * 2004-06-22 2011-03-15 Univ Illinois Verfahren zur inhibierung von tumorzellwachstum mit foxm1 sirns
WO2007109609A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Method for inhibiting angiogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863901A (en) * 1986-01-09 1989-09-05 Brigham & Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions

Also Published As

Publication number Publication date
CA2045546C (en) 2002-06-25
EP0457848B1 (en) 1994-09-07
EP0457848A4 (en) 1992-01-02
JP2855169B2 (ja) 1999-02-10
AU5274990A (en) 1990-09-05
US5089475A (en) 1992-02-18
EP0457848A1 (en) 1991-11-27
CA2045546A1 (en) 1990-08-08
DE69012316D1 (de) 1994-10-13
JPH04503359A (ja) 1992-06-18
DK0457848T3 (da) 1994-12-05
ATE110961T1 (de) 1994-09-15
WO1990009189A1 (en) 1990-08-23
AU634221B2 (en) 1993-02-18
DE69012316T2 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
ES2050070B1 (es) Procedimiento para la preparacion de una composicion destinada a la liberacion prolongada y controlada de una substancia peptidica.
DK0378404T3 (da) Dispenserende indretninger drevet af hydrogel
BR9806802A (pt) Sistema de reforço e crista para uso com implantes dentários
MX9201950A (es) Composiciones de bronceado artificial que contienen vesiculas paucilaminares positivamente cargadas.
BR9811927A (pt) Dispositivo de liberação de agente benéfico propelido por gás que pode ser implantado
ES2038756T3 (es) Dihidrato de azitromicina.
ES2165360T3 (es) Cicloalquenos y cicloalcanos 1,3-sustituidos como agentes del sistema nervioso central.
CO4700344A1 (es) Vacuna polinucleotidica para bovinos por via intradermica
ES2023976B3 (es) Procedimiento para el enriquecimiento de helio.
DE3853384D1 (de) Peptid.
ES2135442T3 (es) Dispositivo de implante.
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
DE59108169D1 (de) Implantierbares Wirkstoffdepotmaterial
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2061021T3 (es) Tratamiento de la dependencia de ventilador con hormona del crecimiento.
DE3789673D1 (de) Selbstansaugendes Zufuhrsystem zur Verabreichung eines Heilmittels.
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
ES2069099T3 (es) Vacuna recombinante para la pleuroneumonia porcina.
ES2172589T3 (es) Tratamiento de la apoplegia asociada con la infiltracion de macrofagos.
NL300112I1 (nl) Vaccin tegen dermatomycosis.
MX9301879A (es) Medicamento para el tratamiento de la inflamacion de las vias respiratorias
ES2188733T3 (es) Sistema de implantacion de sopoorte para protesis dental.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
AR005559A1 (es) Construccion peptidica que tiene un efecto potencializador de la actividad biologica de la hormona del crecimiento, acido nucleico recombinante, composicion que contiene dicha construccion peptidica y uso de dicha composicion y de dicho acido nucleico recombinante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 457848

Country of ref document: ES